お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
967500

分子診断市場

Molecular Diagnostics Market

出版日: | 発行: Datamonitor Healthcare | ページ情報: 英文 95 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.83円
分子診断市場
出版日: 2020年09月30日
発行: Datamonitor Healthcare
ページ情報: 英文 95 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の分子診断の市場規模は、2019年から2024年の間に10.8%のCAGRで成長し、120億米ドル以上の売上に達すると予測されています。同市場は、COVID-19検査の世界的な未曾有の需要により急速に拡大していますが、他のセグメントも大きく成長しています。分子診断は、感染症、腫瘍学、遺伝子疾患の診断とスクリーニング、および他の疾患における新たな用途において幅広く使用されています。

当レポートは、世界の分子診断市場について調査しており、技術の概要や動向、市場の成長および抑制要因、疾患・製品・地域別の市場分析などの情報を提供しています。

当レポート掲載の企業:Roche、Danaher、bioMerieux、Qiagen、Hologic

当レポート調査対象の地域:米国、日本、欧州(フランス、ドイツ、イタリア、スペイン、英国)、およびその他の地域

目次

エグゼクティブサマリー

  • in vitro(イン・ビトロ)分子診断市場
    • 市場成長および抑制要因
    • テクノロジー動向
    • マーケットリーダー
  • 調査手法

第1章 分子診断の臨床概要

  • 感染症検査のための分子診断
    • B型肝炎ウイルス
    • C型肝炎ウイルス
    • ヒト免疫不全ウイルス
    • 結核
    • クラミジアトラコマチス/淋菌
    • ヒトパピローマウイルス
    • メチシリン耐性黄色ブドウ球菌
    • 新規コロナウイルス(COVID-19)
    • その他の感染症
  • 腫瘍学検査のための分子診断
    • 前立腺がん
    • 乳がん
    • 結腸直腸がん
    • その他のがん
  • 遺伝子検査
  • 血液スクリーニング
  • その他の用途
    • 循環器疾患
    • 糖尿病
    • その他の用途
  • 参考文献

第2章 分子診断製品

  • 技術の洞察
    • ポリメラーゼ連鎖反応
    • ハイブリダイゼーション
    • 次世代シーケンシング
    • マイクロアレイ技術
    • その他の技術
  • 感染症検査用
  • 腫瘍学検査用
  • 遺伝子検査用
  • 血液スクリーニング用
  • その他の用途向け
  • 参考文献

第3章 分子診断市場

  • 地域の洞察
    • 米国
    • 欧州市場主要5ヵ国
    • 日本
    • その他の地域
  • 分子診断、製品セグメント別の市場予測
    • 競合分析
  • 分子診断製品市場の動向
    • 償還/経済
    • ラボで開発された検査
  • 市場の成長要因と抑制要因
  • 感染症検査
  • 腫瘍学検査
  • 遺伝子検査
  • 血液スクリーニング
  • その他の用途
  • 参考文献

付録:企業リスト

目次
Product Code: #MDT20012

Overview

Molecular diagnostics is being applied to an increasingly wide range of applications in infectious disease, oncology, and genetic disease diagnosis and screening and to a number of emerging applications in other diseases. The global market for molecular diagnostics is expected to grow at a CAGR of 10.8% between 2019 and 2024, reaching a value of more than $12bn. The market is undergoing rapid expansion due to the unprecedented global demand for COVID-19 testing via molecular methods, but other segments are also experiencing significant growth. Leading competitors in the market include Roche, Danaher, bioMerieux, Qiagen, and Hologic, among others.

This comprehensive medical market and technology report provides:

  • an overview of molecular diagnostics technology, including companion diagnostics
  • in-depth market and competitive analyses
  • product portfolios offered by leading manufacturers
  • disease prevalence data
  • blood collection trends

Markets covered by this analysis include the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets.

Table of Contents

Executive Summary

  • i. In vitro molecular diagnostics market
    • a. Selected market drivers and limiters
    • b. Technology trends
    • c. Market leaders
  • ii. Methodology
    • Exhibit ES-1: Molecular diagnostics products, combined market forecast ($m), by region, 2019-24
    • Exhibit ES-2: Molecular diagnostics products, combined market forecast ($m), by product segment, 2019-24

1. Molecular Diagnostics Clinical Overview

  • 1.1. Molecular diagnostics for infectious disease testing
    • 1.1.1. Hepatitis B virus
    • 1.1.2. Hepatitis C virus
    • 1.1.3. Human immunodeficiency virus
    • 1.1.4. Tuberculosis
    • 1.1.5. Chlamydia trachomatis/Neisseria gonorrhoea
    • 1.1.6. Human papillomavirus
    • 1.1.7. Methicillin-resistant Staphylococcus aureus
    • 1.1.8. Novel coronavirus (COVID-19)
    • 1.1.9. Other infectious diseases
  • 1.2. Molecular diagnostics for oncology testing
    • 1.2.1. Prostate cancer
    • 1.2.2. Breast cancer
    • 1.2.3. Colorectal cancer
    • 1.2.4. Other cancers
  • 1.3. Molecular diagnostics for genetic testing
  • 1.4. Molecular diagnostics for blood screening
  • 1.5. Molecular diagnostics for other applications
    • 1.5.1. Cardiovascular disease
    • 1.5.2. Diabetes
    • 1.5.3. Other applications
  • 1.6. Bibliography
    • Exhibit 1-1: Epidemiology of selected infectious diseases, by region
    • Exhibit 1-2: Daily SARS-CoV-2 molecular test volume in the US
    • Exhibit 1-3: Incidence of selected cancer types, by region, 2018
    • Exhibit 1-4: Incidence of selected cancer types, by region, 2040
    • Exhibit 1-5: Epidemiology of selected genetic diseases, by region
    • Exhibit 1-6: Blood collection trends ('000), by region, 2011-17
    • Exhibit 1-7: Cardiovascular disease mortality ('000), by region, 2011-16
    • Exhibit 1-8: Prevalence of diabetes ('000), by region, 2010-45
    • Exhibit 1-9: Organ transplantation procedures, by region, 2014-18

2. Molecular Diagnostics Products

  • 2.1. Technology insights
    • 2.1.1. Polymerase chain reaction
    • 2.1.2. Hybridization
    • 2.1.3. Next-generation sequencing
    • 2.1.4. Microarray technologies
    • 2.1.5. Other technologies
  • 2.2. Molecular diagnostics products for infectious disease testing
  • 2.3. Molecular diagnostics products for oncology testing
  • 2.4. Molecular diagnostics products for genetic testing
  • 2.5. Molecular diagnostics products for blood screening
  • 2.6. Molecular diagnostics products for other applications
  • 2.7. Bibliography
    • Exhibit 2-1: Selected molecular diagnostics products for infectious disease testing, 2020
    • Exhibit 2-2: Selected molecular diagnostic products for oncology testing, 2020
    • Exhibit 2-3: Selected molecular diagnostics products for genetic testing, 2020
    • Exhibit 2-4: Selected molecular diagnostics products for blood screening, 2020
    • Exhibit 2-5: Selected molecular diagnostics products for other applications, 2020

3. Molecular Diagnostics Market

  • 3.1. Regional insights
    • 3.1.1. US
    • 3.1.2. Five major European markets
    • 3.1.3. Japan
    • 3.1.4. Rest of World
  • 3.2. Molecular diagnostics, market forecast by product segment
    • 3.2.1. Competitive analysis
  • 3.3. Trends in the molecular diagnostics products market
    • 3.3.1. Reimbursement/economic
    • 3.3.2. Laboratory-developed tests
  • 3.4. Market drivers and limiters
  • 3.5. Molecular diagnostic products for infectious disease testing, market analysis
    • 3.5.1. Competitive analysis
  • 3.6. Molecular diagnostics for oncology testing, market analysis
    • 3.6.1. Competitive analysis
  • 3.7. Molecular diagnostics for genetic testing, market analysis
    • 3.7.1. Competitive analysis
  • 3.8. Molecular diagnostics for blood screening, market analysis
    • 3.8.1. Competitive analysis
  • 3.9. Molecular diagnostics for other applications, market analysis
    • 3.9.1. Competitive analysis
  • 3.10. Bibliography
    • Exhibit 3-1: Molecular diagnostics products, combined market forecast ($m), by region, 2019-24
    • Exhibit 3-2: Molecular diagnostics products, combined market forecast ($m), by segment, 2019-24
    • Exhibit 3-3: Molecular diagnostics products, combined market, global share by supplier, 2019
    • Exhibit 3-4: Molecular testing services/LDT market ($m), 2017-19
    • Exhibit 3-5: Molecular diagnostics products for infectious disease testing, market forecast ($m), by geographic region, 2019-24
    • Exhibit 3-6: Molecular diagnostics products for infectious disease testing, global share by supplier, 2019
    • Exhibit 3-7: Molecular diagnostics products for oncology testing, market forecast ($m), by region, 2019-24
    • Exhibit 3-8: Molecular diagnostics products market for oncology testing, share by supplier, 2019
    • Exhibit 3-9: Molecular diagnostics products for genetic testing, market forecast ($m), by region, 2019-24
    • Exhibit 3-10: Molecular diagnostics products for genetic testing, global share by supplier, 2019
    • Exhibit 3-11: Molecular diagnostics products for blood screening, market forecast ($m), by region, 2019-24
    • Exhibit 3-12: Molecular diagnostics products for blood screening, global share by supplier, 2019
    • Exhibit 3-13: Molecular diagnostics products for other applications, market forecast ($m), by region, 2019-24
    • Exhibit 3-14: Molecular diagnostics products for other applications, share by supplier, 2019

APPENDIX: COMPANY LISTING

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.